BiddingSimple
Start FreeLogin
All BidsRadarSavedWhy $9?
Buyer? Post BidsStart Free — 7-day trialLogin

Opportunity timeline

PostedSep 8, 2026
DeadlineSep 15, 2026

In plain English

The National Institute on Drug Abuse seeks pharmacogenomic analysis of participants enrolled in the STAR-B randomized clinical trial of semaglutide for alcohol use disorder. See Notice of Intent NOI-PCA-NIDA-09054 and the attached Statement of Work for details.

About this opportunity

Please see the attached Notice of Intent titled NOI-PCA-NIDA-09054 and Statement of Work.

Time remaining

Closes Sep 15, 2026

01Days
:
13Hours
:
49Min
:
04Sec

Related Opportunities

Veterans Affairs, Department of bids

Certification of Sterile Compounding Facilities Services

Veterans Affairs, Department ofRFI San Antonio, TX Closing today
National Institutes of Health bids

CSS - Large-scale Blood Protein Testing and Data A

National Institutes of HealthRFP Closing today
Veterans Affairs, Department of bids

Water Quality Laboratory Testing Service

Veterans Affairs, Department ofRFP St Cloud, MN Closing today
Veterans Affairs, Department of bids

Water Quality Laboratory Testing Service

Veterans Affairs, Department ofRFP St Cloud, MN Closing today
Veterans Affairs, Department of bids

VHA Black Hills Health Care System Dialysis/SPS Water Testing VOSB Set-Aside

Veterans Affairs, Department ofRFP Fort Meade, SD Closing today

Bid details are gathered and summarized automatically. Please verify details at the original source.

Ref No.

BS-933765